Revive Therapeutics provides update on phase 3 trial of Bucillamine for COVID-19
January 19 2022 - 8:22AM
Seeking Alpha
To read the full story on Seeking Alpha, click
here.
Revive Therapeutics (QB) (USOTC:RVVTF)
Historical Stock Chart
From Aug 2024 to Sep 2024
Revive Therapeutics (QB) (USOTC:RVVTF)
Historical Stock Chart
From Sep 2023 to Sep 2024